Clinically, high-dose treatment with the glucocorticosteroid, methylprednis
olone (MP), within 8 h after spinal cord injury, has been shown to improve
neurological recovery. The current standard of care is to administer MP as
a bolus of 30 mg/kg followed by a 23-h infusion of 5.4 mg/kg/h to spinal co
rd injured patients. To better understand the role of MP in neuroprotection
, we have studied how MP administration affects macrophage accumulation, ti
ssue loss, and axonal dieback at 1, 2, 4 and 8 weeks after a complete trans
ection of the eighth thoracic spinal cord in the adult rat. A 30 mg/kg dose
of MP was administered intravenously at 5 min, and 2 and 4 h after injury.
The number of ED1 (antibody against microglia/macrophages) -positive cells
was quantified in a 500-mu m-wide strip of tissue directly adjacent and pa
rallel to the transection. At all time points, MP treatment led to a signif
icant decrease in the number of ED1-positive cells in both rostral and caud
al stumps. Over the 2-month post-transection period, the average MP-induced
reduction in the number of ED1-positive cells was 82% in the rostral cord
stump and 66% in the caudal stump. Using a computerized image analysis syst
em, it was observed that MP treatment resulted in a significant reduction i
n tissue loss in both cord stumps at 2, 4 and 8 week post-injury. Over the
2-month post-lesion period, the average MP-induced reduction in tissue loss
in the caudal cord stump was higher than that in the rostral stump; 48 ver
sus 37%, respectively. Immunostaining for neurofilaments and growth-associa
ted protein-43 (GAP-43) revealed the presence of numerous axons near and in
the lesion site. Anterograde neuronal tracing with biotinylated dextran am
ine showed that, in MP-treated animals, dieback of vestibulospinal fibres,
but not of corticospinal fibres, was significantly diminished at all time p
oints studied. In addition, with MP administration, 1 and 2 weeks after inj
ury, an increase in the number of vestibulospinal fibres was found at 1 and
2 mm from the transection, suggesting transient regenerative sprouting of
these fibres. The results demonstrate that treatment with MP shortly after
spinal cord transection in the adult rat led to a long-term reduction of ED
1-positive cells and spinal tissue loss, reduced dieback of vestibulospinal
fibres, and a transient sprouting of vestibulospinal fibres near the lesio
n at 1 and 2 weeks post-lesion. The possible relationships between the infl
ammatory changes, spinal tissue sparing, and axonal survival and sprouting
are complex and need to be further explored.